Results of experimental agent suggest promise in lupus nephritis
The investigational agent abetimus significantly lowers anti-double-strand DNA (dsDNA) antibody levels in patients with systemic lupus erythematosus (SLE), according to recent findings....
Want to read complete article? Please Sign in or Register.